|
Volumn 2, Issue SUPPL. 4, 1997, Pages 19-40
|
Current antiretrovirals - A review
|
Author keywords
[No Author keywords available]
|
Indexed keywords
1592;
ABACAVIR;
ANTIVIRUS AGENT;
CARBAMAZEPINE;
CIPROFLOXACIN;
DAPSONE;
DELAVIRDINE;
DIDANOSINE;
GANCICLOVIR;
HYDROXYUREA;
INDINAVIR;
ITRACONAZOLE;
KETOCONAZOLE;
LAMIVUDINE;
NELFINAVIR;
NEVIRAPINE;
ORAL CONTRACEPTIVE AGENT;
PROTEINASE INHIBITOR;
RIFABUTIN;
RIFAMPICIN;
RITONAVIR;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
SAQUINAVIR;
STAVUDINE;
TETRACYCLINE;
THEOPHYLLINE;
UNCLASSIFIED DRUG;
ZALCITABINE;
ZIDOVUDINE;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
ADULT;
ANTIVIRAL ACTIVITY;
BONE MARROW TOXICITY;
CHILD;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG INDUCED DISEASE;
DRUG MECHANISM;
GASTROINTESTINAL TOXICITY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS 1;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
MAJOR CLINICAL STUDY;
META ANALYSIS;
NEPHROLITHIASIS;
NONHUMAN;
ORAL DRUG ADMINISTRATION;
PERIPHERAL NEUROPATHY;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
RASH;
RETROVIRUS;
REVIEW;
VIRUS INFECTION;
|
EID: 0030869810
PISSN: 13596535
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (8)
|
References (145)
|